BACKGROUND AND PURPOSE: Thromboembolism is one of the most serious
complications in coil embolization for intracranial aneurysms, and antiplatelet premedication …

Objectives Low response to antiplatelet drugs is one of the risk factors for ischemic events.
We examined the influence of low response to clopidogrel on symptomatic ischemic events …

Background and purpose Variability in response to clopidogrel therapy is increasingly being
recognized as an important factor in thromboembolic and hemorrhagic complications …

BACKGROUND The use of antiplatelet medications to prevent thrombosis in the treatment of
cerebral aneurysms with stents has become widely emphasized. OBJECTIVE To compare …

Importance Thromboembolism is the most common complication in coiling for an unruptured
aneurysm and is frequent in patients with high on-treatment platelet reactivity (HTPR) who …

BACKGROUND: Thromboembolism is a common complication related to coil embolization
of intracranial aneurysms. OBJECTIVE: To identify factors related to thromboembolic events …

BACKGROUND AND PURPOSE: Prophylactic antiplatelet medication is beneficial in
decreasing thromboembolic complications during endovascular treatment of unruptured …

BACKGROUND AND PURPOSE: Antiplatelet resistance is known to be associated with
symptomatic ischemic complication after endovascular coil embolization. The purpose of our …

Background The mechanisms leading to delayed rupture, distal emboli and
intraparenchymal hemorrhage in relation to pipeline embolization device (PED) placement …

Background: Antiplatelet agents are used during endovascular treatment of cerebral
aneurysms to prevent thromboembolic complications. Objective: The aim of this study was to …